KIAA1524 Polyclonal Antibody
Sizes: 60μL, 120μL, 200μL
Catalogue Numbers: E-AB-14875-60, E-AB-14875-120, E-AB-14875-200
Citations, Manuals and MSDS Available upon request.
Abbreviation: KIAA1524
Target Synonym: Cancerous inhibitor of PP2A; Cancerous Inhibitor of Protein Phosphatase 2A; CIP2A; CIP2A; FLJ12850; Kiaa1524; MGC163436; p90; p90 autoantigen; Protein CIP2A
Research Areas: Cancer
Conjugation: Unconjugated
Host: Rabbit
Species Reactivity: Human, Mouse
Application: WB, ELISA
Isotype: IgG
Clonality: Polyclonal
UNIProt ID: Q8TCG1
Background: Protein CIP2Aalso known ascancerous inhibitor of PP2A(CIP2A) is aproteinthat in humans is encoded by theKIAA1524gene. Protein phosphatase 2A (PP2A) is a cellular tumor suppressor which inhibits cell proliferation and transformation of normal cells to malignant cancer cells. Inhibition of PP2A activity is a prerequisite for human cell transformation. However, the in vivo mechanisms by which PP2A activity is inhibited in spontaneously transformed human cancer cells have been unclear.
Concentration: 0.5 mg/mL
Immunogen: Recombinant protein of human KIAA1524
Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Purification Method: Affinity purification
Dilution: WB 1:500-1:2000
Calculated MW: 102kDa
Storage: -20°C/One year. Avoid freeze / thaw cycles.
Shipping: Ice bag
Research Use Only